share_log

Recent 6.8% Pullback Isn't Enough to Hurt Long-term Cross Country Healthcare (NASDAQ:CCRN) Shareholders, They're Still up 106% Over 3 Years

Recent 6.8% Pullback Isn't Enough to Hurt Long-term Cross Country Healthcare (NASDAQ:CCRN) Shareholders, They're Still up 106% Over 3 Years

最近6.8%的回調不足以傷害長期的越野醫療保健(納斯達克股票代碼:CCRN)股東,他們在3年內仍上漲了106%
Simply Wall St ·  02/09 09:12

Cross Country Healthcare, Inc. (NASDAQ:CCRN) shareholders have seen the share price descend 12% over the month. But that doesn't change the fact that the returns over the last three years have been very strong. Indeed, the share price is up a very strong 106% in that time. After a run like that some may not be surprised to see prices moderate. If the business can perform well for years to come, then the recent drop could be an opportunity.

Cross Country Healthcare, Inc.(納斯達克股票代碼:CCRN)的股東本月股價下跌了12%。但這並不能改變過去三年的回報非常強勁的事實。事實上,當時股價強勁上漲了106%。在這樣的上漲之後,有些人看到價格適中可能並不感到驚訝。如果該業務能夠在未來幾年內表現良好,那麼最近的下跌可能是一個機會。

While this past week has detracted from the company's three-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

儘管過去一週減損了該公司的三年回報率,但讓我們來看看基礎業務的最新趨勢,看看漲幅是否一致。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

儘管一些人繼續教導高效市場假說,但事實證明,市場是反應過度的動態系統,投資者並不總是理性的。研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。

During three years of share price growth, Cross Country Healthcare moved from a loss to profitability. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here.

在三年的股價增長中,Cross Country Healthcare從虧損轉爲盈利。正如我們在這裏看到的那樣,這種轉變可能是一個轉折點,可以證明股價的強勁上漲是合理的。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨着時間的推移)如下圖所示(點擊查看確切數字)。

earnings-per-share-growth
NasdaqGS:CCRN Earnings Per Share Growth February 9th 2024
納斯達克GS:CCRN每股收益增長 2024年2月9日

We know that Cross Country Healthcare has improved its bottom line over the last three years, but what does the future have in store? Take a more thorough look at Cross Country Healthcare's financial health with this free report on its balance sheet.

我們知道Cross Country Healthcare在過去三年中提高了利潤,但是未來會怎樣?通過這份免費的資產負債表報告,更全面地了解Cross Country Healthcare的財務狀況。

A Different Perspective

不同的視角

Investors in Cross Country Healthcare had a tough year, with a total loss of 22%, against a market gain of about 22%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 15%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. It's always interesting to track share price performance over the longer term. But to understand Cross Country Healthcare better, we need to consider many other factors. For example, we've discovered 3 warning signs for Cross Country Healthcare (1 can't be ignored!) that you should be aware of before investing here.

Cross Country Healthcare的投資者經歷了艱難的一年,總虧損了22%,而市場漲幅約爲22%。即使是優質股票的股價有時也會下跌,但我們希望在過於感興趣之前看到企業基本指標的改善。長期投資者不會那麼沮喪,因爲他們本可以在五年內每年賺取15%的收入。如果基本面數據繼續顯示長期可持續增長,那麼當前的拋售可能是一個值得考慮的機會。長期追蹤股價表現總是很有意思的。但是,要更好地了解越野醫療保健,我們需要考慮許多其他因素。例如,我們發現了 Cross Country Healthcare 的 3 個警告信號(1 個不容忽視!)在這裏投資之前,您應該注意這一點。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果你想與管理層一起購買股票,那麼你可能會喜歡這份免費的公司名單。(提示:業內人士一直在購買它們)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論